Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999424 | Urologic Oncology: Seminars and Original Investigations | 2015 | 8 Pages |
Abstract
Preoperative PHI levels may discriminate between patients who are at a high risk vs. low risk of BCR after RARP. External validation of our findings within a larger population with a longer follow-up time is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Giovanni M.D., Massimo M.D., Nicolò Maria M.D., Alberto M.D., Francesco Alessandro M.D., Rodolfo M.D., Luisa M.D., Luigi M.D., Silvia M.D., Roberto M.D., Girolamo M.D., Gianluigi M.D., Paolo M.D., Giorgio M.D.,